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OBJECTIVE—Association between genetic variants at the FTO
locus and obesity has been consistently observed in populations
of European ancestry and inconsistently in non-Europeans. The
aim of this study was to examine the effects of FTO variants on
obesity and type 2 diabetes in Southeast Asian populations.
RESEARCH DESIGN AND METHODS—We examined associ-
ations between nine previously reported FTO single nucleotide
polymorphisms (SNPs) with obesity, type 2 diabetes, and related
traits in 4,298 participants (2,919 Chinese, 785 Malays, and 594
Asian Indians) from the 1998 Singapore National Health Survey
(NHS98) and 2,996 Malays from the Singapore Malay Eye Study
(SiMES).
RESULTS—All nine SNPs exhibited strong linkage disequilib-
rium (r
2  0.6–0.99), and minor alleles were associated with
obesity in the same direction as previous studies with effect sizes
ranging from 0.42 to 0.68 kg/m
2 (P  0.0001) in NHS98 Chinese,
0.65 to 0.91 kg/m
2 (P  0.02) in NHS98 Malays, and 0.52 to 0.64
kg/m
2 (P  0.0001) in SiMES Malays after adjustment for age,
sex, smoking, alcohol consumption, and exercise. The variants
were also associated with type 2 diabetes, though not after
adjustment for BMI (with the exception of the SiMES Malays:
odds ratio 1.17–1.22; P  0.026).
CONCLUSIONS—FTO variants common among European pop-
ulations are associated with obesity in ethnic Chinese and Malays
in Singapore. Our data do not support the hypothesis that
differences in allele frequency or genetic architecture underlie
the lack of association observed in some populations of Asian
ancestry. Examination of gene-environment interactions involv-
ing variants at this locus may provide further insights into the
role of FTO in the pathogenesis of human obesity and diabetes.
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A
recent genome-wide association study for type
2 diabetes using a U.K.-based population re-
vealed a novel locus associated with BMI: the
fat mass– and obesity-related gene (FTO)o n
chromosome 16 (1). The representative single-nucleotide
polymorphism (SNP), rs9939609, was conﬁrmed to be
associated with elevated BMI after replication in more
than 38,000 study participants of European ancestry. Fur-
ther replication of this association has been observed in
several populations of distinctly European ancestry (2–6).
However, this association is inconsistent in populations of
non-European ancestry. A study in Japanese showed an
association between variants at this locus and obesity (7)
that was not observed in African Americans (6) or Han
Chinese (8). The aims of this study were 1) to determine
the associations between previously identiﬁed obesity-
associated SNPs at the FTO locus with obesity and type 2
diabetes in Chinese, Malays, and Asian-Indians and 2)t o
examine whether any associations were modulated by
exercise.
RESEARCH DESIGN AND METHODS
This study utilized data from two cross-sectional studies: the 1998 Singapore
National Health Survey (NHS98) (4,723 subjects) and the Singapore Malay Eye
Study (SiMES) (3,280 subjects). NHS98 is a population-based, cross-sectional
study of Chinese, Malays, and Asian Indians, aged between 18 and 69 years,
that has previously been described (9,10). An interviewer-administered ques-
tionnaire was used to capture data on sociodemographic factors, smoking,
and alcohol consumption. The level of physical activity was categorized into
three groups: those who regularly exercised, deﬁned as participation in any
form of sports for at least 20 min for 3 or more days per week; those who
occasionally exercised (3 days per week); and those who did not exercise.
BMI and blood pressure were measured for all subjects. Waist circumferences
were measured at the narrowest part of the body below the costal margin, and
hip circumference was measured at the widest part of the body below the
waist. Fasting blood samples were drawn for measurement of serum lipids,
glucose, and insulin after a 10-h overnight fast. Type 2 diabetes was deﬁned as
fasting glucose 7.0 mmol/l, 2 h postchallenge glucose (2HPG) 11.1 mmol/l,
or self-reported type 2 diabetes. Impaired fasting glucose/impaired glucose
tolerance was diagnosed if 6.0 mmol/l  fasting glucose 7.0 mmol/l or 7.8
mmol/l  2HPG 11.1 mmol/l.
SiMES is a population-based, cross-sectional epidemiological study of
Malay adults, aged between 40 and 79 years, that has previously been
described (11–14). Serum lipids and glucose were measured in nonfasting
venous samples. Type 2 diabetes was deﬁned as random glucose 11.1 mmol/l
or self-reported type 2 diabetes (additional information regarding the methods
of NHS98 and SiMES can be found in an online appendix, available at
http://dx.doi.org/10.2337/db08-0214).
Genotyping. Genotype data were available for 4,298 NHS98 subjects, com-
prising 2,919 Chinese (1,331 male and 1,588 female), 785 Malays (377 male and
408 female), and 594 Asian Indians (284 male and 310 female). In SiMES,
genotype data were available for 2,996 subjects (1,442 male and 1,554 female).
10 FTO SNPs that have previously been described (1–6,8) were selected for
this study (rs9939609, rs8050136, rs1421085, rs17817449, rs7193144, rs1121980,
rs9940128, rs9939973, rs9926289, and rs9930506). However, rs9930506 failed
assay design and was not genotyped.
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DIABETES, VOL. 57, OCTOBER 2008 2851Genotyping of the remaining nine SNPs was carried out using the Seque-
nom MassARRAY platform (Sequenom, San Diego, CA). All nine SNPs passed
the genotyping call-rate threshold (95%) with an average call rate of 97.7% in
NHS98 samples and 99.5% in SiMES samples. Genotyping success rates for
individual SNPs are listed in Table 1 of the online appendix.
Statistical analysis. Minor allele frequency (MAF), deviation from Hardy-
Weinberg equilibrium (HWE), and linkage disequilibrium (reported as r
2)
were estimated for the nine SNPs using Haploview (15).
All measurement variables that were skewed were normalized by natural
logarithmic transformation. Estimated means were subsequently backtrans-
formed for presentation in the tables. Power calculations were carried out
using QUANTO software (http://hydra.usc.edu/gxe). Based on an MAF of 0.12,
as found in Chinese from Beijing and Shanghai (8), our study had 89% power
( level 0.05) to detect an effect size between 0.4 and 0.5 kg/m
2 in BMI from
NHS98 Chinese and SiMES Malays, similar to effect sizes observed in
populations of European ancestry (0.4–0.66 kg/m
2) (16).
Multiple linear regression analyses were performed to study the associa-
tions between individual SNPs with obesity, blood pressure, and lipid levels.
A general inheritance model was ﬁtted and an additive model used based on
observed effects. Individuals were assigned as 0, 1, or 2 according to their
number of minor/risk alleles, which correspond to the risk alleles associated
with obesity in European populations. Initial analysis did not reveal statisti-
cally signiﬁcant heterogeneity between the sexes (P  0.1); hence, subsequent
analyses were performed with the data from sexes combined with summary
indexes adjusted for sex. All analyses were stratiﬁed by ethnic group. Logistic
regression was used to examine the association between SNPs and categorical
outcomes. To test the hypothesis that exercise may modify the effect of FTO
variants, the interaction variable (SNP/exercise) was included into the regres-
sion models. The likelihood ratio test was used to estimate the P values for
interaction by comparing the regression models with and without the inter-
action term. Where stated, adjustment for age, sex, BMI, current smoking,
alcohol intake, and regular exercise was carried out by adding these variables
to the model. Meta-analysis was performed to determine the pooled effects
across all four populations studied using the inverse variance–weighted
method. A test of heterogeneity of effects between populations was carried
out using Cochran’s test of heterogeneity. These statistical analyses were
performed using STATA (version 9.1 for Windows). We also carried out
haplotype-based analyses, the methods for which are described in the online
appendix.
RESULTS
Table 1 shows the clinical characteristics of the two study
populations. Allele frequencies for the nine genotyped
SNPs and test for HWE deviation are listed in online
appendix Table 1. The MAFs for all nine SNPs were higher
in Asian Indians (0.33–0.43) than in Malays (0.28–0.33) or
Chinese (0.12–0.18). None of the SNPs showed signiﬁcant
deviation from HWE. Figure 1 illustrates the linkage
disequilibrium between the nine FTO SNPs in the different
ethnic populations. A high degree of linkage disequilib-
rium was observed between the SNPs, with similar pat-
terns in all three ethnic groups in our population. In
addition, the linkage disequilibrium structure of our pop-
ulation showed similarity to that of the European popula-
tion (CEU population of HapMap [online appendix Fig. 1]).
Table 2 shows associations between the nine SNPs with
obesity, impaired fasting glucose/impaired glucose toler-
ance, and type 2 diabetes. All nine FTO SNPs were
associated with increased BMI with an effect size, per risk
allele, of 0.42–0.68 kg/m
2 (P  0.0001) in NHS98 Chinese,
0.65–0.91 kg/m
2 (P  0.02) in NHS98 Malays, and 0.52–0.64
kg/m
2 (P  0.0001) in SiMES Malays. FTO variants were
also associated with an increased risk of type 2 diabetes in
the NHS98 Chinese (odds ratio 1.32–1.42; P  0.049),
NHS98 Malays (1.52–1.63; P  0.028) and SiMES Malays
(1.20–1.24; P  0.007). However, these associations were
abolished after adjustment for BMI, except in the SiMES
Malays (1.17–1.22; P  0.026). No statistically signiﬁcant
associations were observed in Asian Indians.
We next examined the association between FTO SNPs
with obesity-related traits. Table 3 summarizes the associ-
ation between rs9939609 and these traits. We chose
rs9939609 as the representative SNP in our study because
it was the index SNP in the original study (1) and had one
TABLE 1
Clinical characteristics of the NHS98 and SiMES study populations
NHS 98 SiMES
Chinese Malay Indian Malay
n 2,919 785 594 2,996
Male (%) 45.6 47.9 47.8 48.1
Age (years) 37.9  12.2 38.9  12.5 40.6  11.9 58.6  11.0
BMI (kg/m
2) 22.7  3.71 25.5  4.96 25.1  4.60 26.3  5.11
Waist-to-hip ratio 0.82  0.07 0.83  0.07 0.85  0.07 NA
Waist circumference (cm) 78.1  10.6 82.6  11.9 85.1  11.5 NA
HDL cholesterol (mmol/l) 1.42  0.37 1.30  0.33 1.14  0.30 1.35  0.33
LDL cholesterol (mmol/l) 3.38  0.95 3.86  1.08 3.69  1.03 3.54  1.00
Triglycerides (mmol/l) 1.40  1.19 1.67  1.28 1.68  1.36 1.60  1.32
Total cholesterol (mmol/l) 5.41  1.04 5.81  1.15 5.51  1.10 5.62  1.16
Fasting plasma glucose (mmol/l) 5.62  1.30 6.09  2.23 6.23  2.17 NA
2HPG (mmol/l) 6.65  2.76 7.37  3.55 7.63  4.07 NA
Systolic blood pressure (mmHg) 120.  16.3 124.  19.3 121.  17.1 147.  23.7
Diastolic blood pressure (mmHg) 73.7  11.2 76.0  12.0 73.6  12.0 79.7  11.2
Hypertension 18.6 25.9 20.2 68.5
Glucose tolerance (%)
Normal 2,179 (74.7) 473 (60.2) 362 (60.9) 2,288 (76.4)*
IFG/IGT 515 (17.6) 201 (25.6) 118 (19.8) NA
Type 2 diabetes 224 (7.7) 111 (14.1) 114 (19.2) 708 (23.6)
Currently smoking (%) 12.4 22.9 14.6 20.2
Regularly exercise (%)† 14.7 17.6 22.8 NA
Consume alcohol (%)‡ 45.1 7.3 33.3 1.6
Data are means  SD or n (%) unless otherwise indicated. *SiMES participants with no diabetes; †regular exercise deﬁned as participation
in any form of sports for at least 20 min for 3 or more days per week; ‡individuals who consume at least 1 alcoholic beverage per month.
IFG/IGT, impaired fasting glucose/impaired glucose tolerance; NA, not applicable.
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rs9939609 also showed highly signiﬁcant association with
waist circumference in both NHS98 Chinese (P  0.0001)
and NHS98 Malay (P  0.001); waist circumference data
were not available for SiMES Malays. Borderline associa-
tion was also observed with LDL cholesterol and triglyc-
eride, the latter only after adjustment for BMI, in NHS98
Chinese samples. Details of the associations for the other
SNPs are listed in online appendix Table 2. Meta-analysis
of the association between this SNP and BMI for all four
populations in our study was also performed. No signiﬁ-
cant heterogeneity was observed between the four popu-
lations, and the pooled effect size was BMI 0.62 kg/m
2 (95%
CI 0.45–0.80; P  2  10
12). Haplotype-based analyses
recapitulated ﬁndings from individual SNP analyses; these
results are shown in online appendix Table 3.
We also examined the interaction between rs9939609
and physical activity in relation to BMI (online appendix
Fig. 2). Although it appeared that rs9939609 had a smaller
effect on BMI in those who exercised regularly, the inter-
action was not statistically signiﬁcant (P  0.248).
DISCUSSION
In our study, FTO variants showed associations with
obesity and type 2 diabetes in Chinese and Malays living in
Singapore. Similar effects were not observed in Asian
Indian samples from the NHS98 cohort. However, it should
be noted that given the relatively small sample size (n 
594) for this ethnic group, we had only 40% power to
detect changes in BMI of 0.5 kg/m
2 for this population.
Furthermore, meta-analysis showed no heterogeneity of
effect between populations. We also examined the associ-
ation between these SNPs and other obesity-related traits.
Other than a strong association with waist circumference,
only borderline associations were observed with LDL
cholesterol and triglycerides. A recent study by Freathy et
al. (17) showed associations with LDL cholesterol in the
same direction as that observed in our study. Their study
also suggested that much larger sample sizes than are
currently available are required to detect the effect of
these genetic variants on secondary traits related to obe-
sity. Given the multiple associations tested, we also cannot
exclude the possibility that these could represent false-
positive ﬁndings.
Results from our NHS98 Chinese subjects are in line
with ﬁndings in a Japanese study (7) but in contrast to
those of a recent study by Li et al. (8) describing the lack
of association between FTO variants and obesity in Han
Chinese resident in China. Our study had a similarly large
sample size (n  2,919 for NHS98 Chinese vs. n  3,210 for
A NHS98 Chinese
C NHS98 Asian-Indians D SiMES Malay
B NHS98 Malay
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FIG. 1. Linkage disequilibrium (r
2) between the nine FTO SNPs in the NHS98 and SiMES populations.
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DIABETES, VOL. 57, OCTOBER 2008 2853Han Chinese) and, as described in RESEARCH DESIGN AND
METHODS, was more than adequately powered to detect an
effect size on BMI similar to that observed in populations
of European ancestry. The authors suggested that the
lower MAFs and differences in genetic architecture at this
locus between Europeans and Chinese may have contrib-
uted to the lack of association in other ethnic groups. It
has been suggested that population differences in the
patterns of association such as these may occur as a result
of an evolutionary divergence that might reﬂect a history
of negative selection against the FTO risk alleles in African
and Chinese populations, as has been suggested in relation
to variants at the TCF7L2 locus (18). However, it seems
unlikely that any of these hypotheses provide an explana-
tion for these different ﬁndings. The MAFs of FTO SNPs
examined were very similar between the Chinese in our
population and the Han Chinese from Beijing and Shang-
hai, yet we observed a strong association with obesity.
Importantly, we studied two of the three SNPs tested by Li
et al. in Chinese Hans (rs8050136 and rs9939609), both of
which were strongly associated with obesity traits. Fur-
thermore, comparisons of linkage disequilibrium patterns
between our study populations and European (CEU) pop-
ulations from HapMap (excluding rs9926289, where no
data were available based on NCBI Build36) revealed no
major differences in this region. The nine SNPs tested
were correspondingly in strong linkage disequilibrium
with each other in our Chinese (r
2  0.60–0.99), Malay
(r
2  0.77–0.99 in NHS98 and r
2  0.80–0.99 in SiMES),
and Asian Indian (r
2  0.64–0.99) samples, as they were in
the CEU population from HapMap (r
2  0.83–0.96 [online
appendix Fig. 1]).
The common form of obesity is a multifactorial condi-
tion thought to develop from an intricate interplay of
genes and environmental factors such as dietary habits
and levels of physical activity. The occurrence of gene-
gene and gene-environment factors would, therefore,
make it difﬁcult to clearly elucidate the role of speciﬁc
TABLE 2
Association between nine FTO SNPs with obesity, risk of type 2 diabetes, and impaired fasting glucose/impaired glucose tolerance
(IFG/IGT) in the NHS98 and SiMES populations
SNP rs9939973 rs9940128 rs1421085 rs1121980
NHS98 Chinese (n  2,919)
BMI per risk allele present
(kg/m
2) 0.43 0.42 0.68 0.43
P*/P† 0.0001/0.0001 0.001/0.0001 0.0001/0.0001 0.0001/0.0001
Glucose tolerance
OR (95% CI)* for type 2
diabetes vs. NGT 1.33 (1.01–1.74) 1.32 (1.00–1.72) 1.42 (1.04–1.93) 1.19 (0.91–1.53)
P*/P† 0.036/0.132 0.043/0.15 0.024/0.128 0.187/0.434
OR (95% CI) for IFG/IGT
vs. NGT* 1.10 (0.91–1.32) 1.09 (0.90–1.31) 1.15 (0.92–1.42) 1.08 (0.90–1.29)
P*/P† 0.323/0.527 0.338/0.546 0.197/0.503 0.368/0.702
NHS98 Malay (n  785)
BMI per risk allele present
(kg/m
2) 0.83 0.82 0.90 0.65
P*/P† 0.001/0.002 0.002/0.002 0.001/0.001 0.011/0.015
Glucose tolerance
OR (95% CI)* for type 2
diabetes vs. NGT 1.61 (1.10–2.33) 1.60 (1.09–2.32) 1.59 (1.09–2.32) 1.57 (1.08–2.25)
P*/P† 0.013/0.082 0.014/0.084 0.016/0.095 0.016/0.071
OR (95% CI) for IFG/IGT
vs. NGT* 1.34 (1.03–1.74) 1.35 (1.03–1.74) 1.22 (0.93–1.58) 1.37 (1.06–1.77)
P*/P† 0.028/0.075 0.025/0.067 0.144/0.331 0.015/0.033
NHS98 Asian-Indians (n  594)
BMI per risk allele present
(kg/m
2) 0.24 0.23 0.03 0.28
P*/P† 0.352/0.333 0.36/0.347 0.913/0.781 0.267/0.247
Glucose tolerance
OR (95% CI)* for type 2
diabetes vs. NGT 0.84 (0.59–1.19) 0.85 (0.59–1.20) 0.87 (0.60–1.25) 0.94 (0.66–1.31)
P*/P† 0.341/0.356 0.349/0.365 0.467/0.564 0.711/0.74
OR (95% CI) for IFG/IGT
vs. NGT* 0.95 (0.69–1.29) 0.96 (0.70–1.30) 0.90 (0.65–1.24) 1.05 (0.77–1.41)
P*/P† 0.754/0.707 0.775/0.732 0.515/0.509 0.774/0.895
SiMES Malay
BMI per risk allele present
(kg/m
2) 0.55 0.55 0.64 0.52
P*/P† 0.0001/0.0001 0.001/0.0001 0.0001/0.0001 0.0001/0.0001
Glucose tolerance
OR (95% CI)* for type 2
diabetes vs. NGT 1.23 (1.08–1.40) 1.24 (1.08–1.40) 1.20 (1.05–1.37) 1.24 (1.08–1.40)
P*/P† 0.001/0.004 0.001/0.004 0.007/0.025 0.001/0.003
Continued on following page
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already recognized the signiﬁcance of environmental mod-
ulation in variants of LIPC, APOA5, and PPARG with
metabolic traits (20). Likewise, possible explanations for
the differences in associations seen in our population
compared with the ﬁndings of Li et al. (8) could lie in
different exposures to environmental or lifestyle factors
between the populations. For example, Andreason et al.
(4) reported that physical activity attenuated the effects of
the FTO variants on obesity. This may be relevant given
that studies in Shanghai Chinese by Lee et al. (21) and Jurj
et al. (22) have reported that an average of 35% of subjects
participated in regular exercise compared with 14.7% of
the NHS98 Singapore Chinese population. While our study
found no signiﬁcant interaction with physical activity, our
study may have been underpowered to detect these inter-
actions (assuming an MAF of 12%, we only had 40% power
at an  level of 0.05). Furthermore, recent ﬁndings related
to the association between ROBO1 variants and obesity
have emphasized the importance of age-gene interactions
that may result in nonreplication (23). The differences in
average age between the two Chinese populations (37.9 
12.2 years in NHS98 Chinese vs. 58.6  6.0 years in Han
Chinese) may have contributed to the discrepancies. Al-
though this is an interesting hypothesis, it should be noted
that the FTO associations with BMI showed no heteroge-
neity across populations of European ancestry with
greatly varying mean ages (1).
Interestingly, adjustment for BMI diminished but did not
abolish the association with type 2 diabetes among SiMES
Malays. Perhaps this indicates a direct effect of FTO with
type 2 diabetes, which, to the best of our knowledge, has
not been observed in other studies. Another possibility
could relate to residual confounding by obesity. It is well
known that compared with Caucasians of similar BMI,
Asians have different levels of adiposity and, thus, risks of
TABLE 2
Continued
rs7193144 rs17817449 rs8050136 rs9926289 rs9939609
0.63 0.67 0.68 0.68 0.66
0.0001/0.0001 0.0001/0.0001 0.0001/0.0001 0.0001/0.0001 0.0001/0.0001
1.42 (1.04–1.92) 1.39 (1.01–1.90) 1.40 (1.02–1.90) 1.40 (1.02–1.90) 1.37 (1.00–1.86)
0.025/0.102 0.039/0.178 0.036/0.168 0.035/0.163 0.049/0.212
1.10 (0.89–1.37) 1.14 (0.91–1.41) 1.14 (0.91–1.40) 1.14 (0.92–1.41) 1.12 (0.89–1.38)
0.366/0.729 0.241/0.578 0.25/0.611 0.223/0.568 0.313/0.684
0.82 0.91 0.86 0.88 0.89
0.002/0.002 0.001/0.001 0.001/0.002 0.001/0.001 0.001/0.001
1.52 (1.04–2.21) 1.63 (1.11–2.38) 1.53 (1.04–2.24) 1.60 (1.09–2.32) 1.57 (1.08–2.29)
0.027/0.12 0.011/0.074 0.028/0.129 0.015/0.092 0.018/0.104
1.21 (0.93–1.57) 1.25 (0.95–1.63) 1.20 (0.91–1.56) 1.24 (0.95–1.61) 1.22 (0.93–1.59)
0.154/0.331 0.103/0.243 0.186/0.392 0.113/0.267 0.136/0.318
0.12 0.10 0.04 0.11 0.10
0.658/0.458 0.715/0.527 0.877/0.719 0.674/0.487 0.7/0.532
0.93 (0.64–1.32) 0.85 (0.58–1.23) 0.87 (0.60–1.24) 0.88 (0.61–1.27) 0.96 (0.67–1.37)
0.677/0.766 0.393/0.438 0.445/0.53 0.51/0.543 0.84/0.914
0.88 (0.63–1.21) 0.85 (0.60–1.17) 0.91 (0.66–1.25) 0.87 (0.62–1.20) 0.87 (0.63–1.20)
0.432/0.404 0.327/0.294 0.576/0.565 0.411/0.378 0.419/0.369
0.62 0.64 0.63 0.61 0.64
0.0001/0.0001 0.0001/0.0001 0.0001/0.0001 0.0001/0.0001 0.0001/0.0001
1.21 (1.05–1.37) 1.20 (1.05–1.37) 1.20 (1.05–1.37) 1.20 (1.05–1.37) 1.21 (1.05–1.38)
0.005/0.019 0.007/0.026 0.007/0.023 0.006/0.021 0.005/0.019
*Adjusted for age and sex; †adjusted for age, sex, current smoking, exercise (except in the SiMES population), BMI (for risk of type 2
diabetes), education, and alcohol consumption. NGT, normal glucose tolerance.
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not fully account for the confounding effects of adiposity
on the risk of type 2 diabetes in the SiMES Malays.
In conclusion, we have found that variants at the FTO
locus are associated with obesity in ethnic Chinese and
Malays living in Singapore. In addition, statistically signif-
icant associations with type 2 diabetes were observed in
Chinese and Malays. These two ethnic groups represent a
large proportion of the population living in Southeast Asia,
a region wherein a dramatic increase in the burden of
diabetes is anticipated over the next several decades (25).
Our ﬁndings make it unlikely that differences in allele
frequency or genetic architecture underlie the lack of
association reported between these variants and obesity-
related traits in Chinese Hans (8). However, it is still
possible that varied linkage disequilibrium structures and
lower MAFs could reduce power to detect associations in
other populations. Given these ﬁndings, it seems impor-
tant to explore interactions between these genetic variants
with lifestyle factors (e.g., physical activity) to better
elucidate possible gene-environmental interactions that
may underlie population differences.
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